Chapters

Transcript

Video

How do we identify patients in late adolescence who might benefit from reductions in steroid dose? And who might be ideal candidates for CRF antagonists such as crinecerfont?

How do we identify patients in late adolescence who might benefit from reductions in steroid dose? And who might be ideal candidates for CRF antagonists such as crinecerfont?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Perrin White, MD

Perrin White, MD

Chief, Division of Pediatric Endocrinology
Audre Newman Rapoport Distinguished Chair in Pediatric Endocrinology
UT Southwestern Medical Center
Dallas, TX